Follow
Farzaneh Moghadam
Farzaneh Moghadam
University of Pittsburgh
Verified email at asu.edu
Title
Cited by
Cited by
Year
Multifunctional CRISPR-Cas9 with engineered immunosilenced human T cell epitopes
SR Ferdosi, R Ewaisha, F Moghadam, S Krishna, JG Park, ...
Nature communications 10 (1), 1842, 2019
1682019
Gene regulatory network analysis and engineering directs development and vascularization of multilineage human liver organoids
JJ Velazquez, R LeGraw, F Moghadam, Y Tan, J Kilbourne, JC Maggiore, ...
Cell systems 12 (1), 41-55. e11, 2021
672021
Development of a DNA-liposome complex for gene delivery applications
M Rasoulianboroujeni, G Kupgan, F Moghadam, M Tahriri, A Boughdachi, ...
Materials Science and Engineering: C 75, 191-197, 2017
622017
Engineered CRISPR systems for next generation gene therapies
M Pineda, F Moghadam, MR Ebrahimkhani, S Kiani
ACS synthetic biology 6 (9), 1614-1626, 2017
372017
Synthetic immunomodulation with a CRISPR super-repressor in vivo
F Moghadam, R LeGraw, JJ Velazquez, NC Yeo, C Xu, J Park, A Chavez, ...
Nature cell biology 22 (9), 1143-1154, 2020
302020
Chuva de Sousa Lopes, SM; et al
JJ Velazquez, R LeGraw, F Moghadam, Y Tan, J Kilbourne, JC Maggiore, ...
Gene regulatory network analysis and engineering directs development and …, 2021
202021
Chuva de Sousa Lopes SM et al (2021) Gene regulatory network analysis and engineering directs development and vascularization of multilineage human liver organoids
JJ Velazquez, R LeGraw, F Moghadam, Y Tan, J Kilbourne, JC Maggiore, ...
Cell Syst 12, 41-55, 0
14
Draft genome sequence and detailed analysis of Pantoea eucrina strain Russ and implication for opportunistic pathogenesis
F Moghadam, MB Couger, B Russ, R Ramsey, RA Hanafy, C Budd, ...
Genomics data 10, 63-68, 2016
102016
Multifunctional CRISPR-Cas9 with engineered immunosilenced human T cell epitopes. Nat Commun. 2019; 10 (1): 1842
SR Ferdosi, R Ewaisha, F Moghadam, S Krishna, JG Park, ...
5
Synthetic maturation of multilineage human liver organoids via genetically guided engineering
JJ Velazquez, R LeGraw, F Moghadam, Y Tan, J Kilbourne, J Hislop, ...
BioRxiv, 2020.05. 10.087445, 2020
42020
CRISPR-Based Synthetic Gene Circuits as Next Generation Gene Therapy of Inner Ear
S Kiani, S Pradhan, F Moghadam, MR Ebrahimkhani
US Patent App. 16/626,013, 2021
12021
Synthetic immunomodulation with a crispr super-repressor in vivo
S Kiani, MR Ebrahimkhani, F Moghadam
US Patent App. 18/535,658, 2024
2024
Synthetic immunomodulation with a CRISPR super-repressor in vivo
S Kiani, MR Ebrahimkhani, F Moghadam
US Patent 11,884,925, 2024
2024
CRISPR logic circuits for safer and controllable gene therapies
S Kiani, MR Ebrahimkhani, S Pradhan, F Moghadam
US Patent 11,773,407, 2023
2023
Modulating Human Cas9-Specific Host Immune Response
S Kiani, R Ewaisha, SR Ferdosi, K Anderson, F Moghadam, S Krishna, ...
US Patent App. 17/546,810, 2022
2022
Modulating human Cas9-specific host immune response
R Ewaisha, S Kiani, SR Ferdosi, K Anderson, F Moghadam, S Krishna, ...
US Patent 11,208,640, 2021
2021
Developing safe and controllable Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)-based therapies with design principles of synthetic biology
F Moghadam
Arizona State University, 2020
2020
Genetically guided engineering of human liver tissue from pluripotent stem cells
M Ebrahimkhani, J Velzaquez, R Legraw, F Moghadam, J Kilbourne, ...
42nd Society for Biomaterials Annual Meeting and Exposition 2019: The …, 2019
2019
The system can't perform the operation now. Try again later.
Articles 1–18